While advocacy to raise awareness about mitochondrial diseases around the world is ongoing, these efforts get a boost each year during the third week of September, which is dedicated to Mitochondrial Disease Awareness Week. Its aim is to increase the spotlight on the need for more research to uncover new therapies. Read More
It's a double whammy for cardiovascular drug developers, according to a new study from the Tufts Center for the Study of Drug Development. It's taking longer to get a cardiovascular drug through the clinic and onto market. And more drugs are failing along the way. Read More
